Shorewind Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechEmeryville, US
Maximilian HörnerinMax Huisman(Chief Technology Officer & Co-Founder)inDeniz Kent(Chief Executive Officer & Co-Founder)inDeniz Kent, Ph.D.(Founder)inDeclan Jones(Founder)inShahram Misaghiin
Co-investorsBaruch Future VenturesBreakthrough Energy VenturesDarco CapitalMayfield FundSolari CapitalSOSV+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.